NOCTURNAL
LIVE

Serial Number

97175653

Owner

Nocturnal Product Development, LLC

Attorney

Devon E. White

Filing Date

Dec 16, 2021

Add to watchlist:

No watchlists yet
View on USPTO

NOCTURNAL Trademark

Serial Number: 97175653 • Registration: 7141791

NOCTURNAL is a trademark filed by Nocturnal Product Development, LLC on December 16, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Nocturnal Product Development, LLC

8128 Renaissance Pkwy #210,
Durham, NC 27713

Entity Type: 16

Trademark Details

Filing Date

December 16, 2021

Registration Date

August 22, 2023

Published for Opposition

June 6, 2023

Goods & Services

business financial and funding consulting services, namely, providing information that advises companies and universities seeking to obtain grant funding from federal, state, and local governments for clinical research and clinical trials

business consulting services, namely, providing assistance in the development of innovation-driven business strategies and creative ideation; business consulting in the field of clinical trials, namely, assisting with clinical data and regulatory submission management on behalf of medical, biopharmaceutical, and biotechnology companies; business consulting services, namely, providing information to companies and universities on managing grant funding from federal, state, and local governments for clinical research and clinical trials; business consulting services, namely, maintaining design history files, performing business risk analysis, and planning and executing verification and validation activities that support clinical investigations in domestic and international settings, namely, providing independent review of clinical trials for business purposes, developing regulatory strategies for obtaining domestic and international approvals in the nature of clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with applications for drug and medical device approval, and assisting businesses in preparing and filing applications for and managing government grant funding in the field of medical devices and products; business consulting services, namely, assisting with clinical trial submissions, namely, regulatory submission management, namely, assisting others in preparing and filing applications for new drugs and new medical devices with governmental regulatory bodies; business consulting services, namely, assisting in obtaining domestic and international approvals by developing regulatory strategies and authoring product approval and product registration submissions; business consulting services, namely, project management services to identify and mitigate potential risks in complex projects; business consulting services, namely, consultation in the fields of medical products and medical devices

product research and development in the fields of medical products and medical devices; mechanical engineering services for electronics packaging, structural finite element analysis, and thermal analysis; product design and development in the field of medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software to meet the demands of medical products and medical devices; product design and development in the field of medical devices, namely, electromagnetic compatibility (EMC) and electrical safety testing to meet the demands of international regulatory standards; product design and development in the field of medical products and medical devices, namely, development of laser systems, fiber and electro-optics, and biophotonics for spectroscopy and optical characterization of living tissue via both diffuse reflectance and fluorescence; cloud-based Platform as a Service (PaaS) featuring computer software platforms that communicate with and collect data from medical products and medical devices; product design and development in the field of medical products and medical devices, namely, developing extensive analog circuitry, digital circuitry, embedded firmware, and application software for use with medical products and medical devices including topical electronic medical devices, active electronic implants, implantable pacemakers, defibrillators, diagnostic catheters, ablation catheters, and neurostimulators; business product development consulting services, namely, providing assistance in the development of leading-edge technologies for medical, biopharmaceutical, and biotechnology companies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 22, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 22, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 6, 2023 NPUB
PUBLISHED FOR OPPOSITION
Jun 6, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 17, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 10, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 10, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Apr 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Apr 7, 2023 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 22, 2022 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 22, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 21, 2021 NWOS
NEW APPLICATION ENTERED
Dec 20, 2021 NWAP